What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Sai Life Sciences Limited IPO?

Sai Life Sciences Limited IPO has received a total subscription of 10.27 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Sai Life Sciences Limited

ListedMainboard

Pharmaceuticals & Healthcare · NSE / BSE

Sai Life Sciences Limited, incorporated in January 1999, specializes in researching, developing, and manufacturing small-molecule new chemical entities, serving over 280 innovator pharmaceutical companies in FY 2024, including more than 230 clients as of September 2024. Collaborating with 18 of the top 25 global pharmaceutical firms, the company provides services across the US, UK, Europe, and Japan, offering CMC/CDMO capabilities, integrated discovery through CRO services, and support in biology, chemistry, and pharmacokinetics. Supported by a workforce of 3,135 employees, including 2,353 scientific staff with 302 Ph.D.s and 1,475 master’s degrees, Sai Life Sciences drives innovation with a globally positioned business development team of 16 professionals.

Price Band

₹522 – ₹549

Issue Size

₹3043 Cr

Lot Size

27 shares

GMP

₹71

+12.9%

Est. Listing

₹620

at current GMP

Subscribed

10.27x

overall

Open

11 Dec 2024

13 Dec 2024

Allotment

16 Dec 2024

Refund

17 Dec 2024

Demat Credit

18 Dec 2024

Listing

18 Dec 2024

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

10.27x

Total Demand

QIB Multiplier

29.78x

Institutions & Funds

NII / HNI

4.99x

High Net-Worth

Retail (RII)

1.39x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 10.27x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	11,084,226	330,125,058	29.78x
NIB	8,313,169	41,522,058	4.99x
HNIs(10L +)	5,542,112	33,813,693	6.10x
HNIs (2-10L)	2,771,056	7,708,365	2.78x
RETAIL	19,397,393	26,912,412	1.39x
Total	47,107,956	440,081,586	10.27x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.49x

Category	Applications Reserved	Applications Received	Times Subscribed
RETAIL	718,422	996,756	1.39x
HNIs(10L +)	14,662	89,454	6.10x
HNIs (2-10L)	7,331	20,392	2.78x
Total Applications	740,415	1,106,602	1.49x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Sai Life Sciences Limited Public Issue & Market Profile

Sai Life Sciences Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹3,042.62 Crores. The shares are offered at a price band of ₹522 to ₹549 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2024-12-13, the basis of allotment is scheduled to be finalized on 2024-12-16. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Sai Life Sciences Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Sai Life Sciences Limited IPO is ₹71 per equity share. Based on the upper price band of ₹522 to ₹549 per equity share, the estimated listing price is ₹620 (+12.9% expected listing gain).

What is the expected profit per lot for Sai Life Sciences Limited IPO?

With a lot size of 27 shares and current GMP of ₹71, the expected profit per application lot is approx ₹1,917 (+12.9% gain). Minimum application cost is approx ₹14,823.

What is the issue size and price band for Sai Life Sciences Limited IPO?

The Sai Life Sciences Limited IPO aggregate issue size is ₹3,042.62 Crores with an equity price band set at ₹522 to ₹549 per equity share. The retail lot size is 27 shares requiring a minimum capital outlay of approx. ₹14,823.

How can I check Sai Life Sciences Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 10.27x (Retail: 1.39x, QIB: 29.78x, NII: 4.99x). You can track live multiples directly on our dedicated subscription page.

Where and when will Sai Life Sciences Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2024-12-16. Investors can verify status using PAN card or application number.

When is the listing date for Sai Life Sciences Limited IPO?

Sai Life Sciences Limited shares are scheduled to list on NSE and BSE on 2024-12-18.